Stocktoria
IONIS PHARMACEUTICALS INC IONS
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 1991-05-17
IONIS PHARMACEUTICALS INC financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $943.7M | $705.1M | $787.6M | $587.4M | $810.5M |
| R&D expense | $915.6M | $901.5M | $899.6M | — | $638.2M |
| SG&A expense | $393.9M | $267.5M | $232.6M | $150.3M | $186.3M |
| Operating income | -$381.7M | -$475.1M | -$353.7M | -$410.2M | -$30.2M |
| Interest expense | $17.3M | $17.0M | $12.7M | $8.1M | $9.3M |
| Income tax | $1.8M | -$6.2M | $32.3M | $11.7M | -$551,000 |
| Net income | -$381.4M | -$453.9M | -$366.3M | -$269.7M | -$28.6M |
| EPS (diluted) | $-2.38 | $-3.04 | $-2.56 | $-1.90 | $-0.20 |
| Operating cash flow | -$268.6M | -$500.9M | -$307.5M | -$274.4M | $30.8M |
| Free cash flow | -$320.0M | -$546.2M | -$331.3M | -$290.1M | $18.8M |
| Cash & equivalents | $372.3M | $242.1M | $399.3M | $276.5M | $869.2M |
| Inventory | $10.0M | $12.5M | $7.4M | $22.0M | $24.8M |
| Total assets | $3.5B | $3.0B | $3.0B | $2.5B | $2.6B |
| Total liabilities | $3.0B | $2.4B | $2.6B | $2.0B | $1.8B |
| Shareholders' equity | $489.1M | $588.4M | $386.7M | $572.9M | $771.7M |
Source: SEC EDGAR filings · CIK 0000874015 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.